African Journal of Biotechnology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

 

Afr. J. Biotechnol.


Vol. 5 No.
10



Viewing options:


 • Abstract
 • Full text
 • Reprint (PDF) (1,134 K)

Search Pubmed for articles by:

 

El Rayah IE

El Malik KH

 

Other links:


PubMed Citation


Related articles in PubMed

 

African Journal of Biotechnology Vol. 5 (10), pp. 951-955, 16 May 2006   

ISSN 1684–5315 © 2006 Academic Journals        

 

Full Length Research Paper

 

Characterization of quinapyramine (Trypacide®) drug-resistant Trypansoma evansi

 

Intisar E. El Rayah1* and Khitma H. El Malik2

 

Trypanosomosis Unit, Tropical Medicine Research Institute (TMRI), P.O.BOX 1304, Khartoum 11111, Sudan.

2Faculty of Veterinary Science, University of Khartoum, P.O Box 32, Khartoum North, Sudan.

 

*Corresponding authors E-mail: intisar62@yahoo.com, trypanosome@sudanmail.net.sd, Tel: 249-9-12234657, Fax: 249-1-83-781845.

 

Accepted 30 March, 2006

 
   

Abstract


 

 

 

Molecular karyotyping by pulsed field gel electrophoresis was used to characterize Trypanosoma evansi isolates. Ten T. evansi isolates from camels were collected in Eastern and Western Sudan. Isolates from Eastern Sudan which were kept under continuous prophylactic treatment with quinapyramine (Trypacide®), were found to bear a single pattern and belonged to one karyotype group. From Western Sudan where trypanosomosis management was done by individual treatment of proven parasitaemic cases, isolates with diverse karyotype patterns were obtained. This study concluded that the occurrence of karyotype homogeneity amongst T. evansi isolates from field situations where anti-trypanosomal compounds have been used may infer the existence of drug-resistance.

 

Key words: Trypanosoma evansi, drug resistance, Trypacide®, karyotyping, Sudan.

 

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Copyright © 2006 by Academic Journals.